Interleukin-8 (IL-8/CXCL8) is an important neutrophil
chemoattractant known to be elevated in the airways of cigarette smokers and in patients with
chronic obstructive pulmonary disease (
COPD). We examined the acute effect of aqueous cigarette
smoke extract (CSE) on
IL-8 expression in primary human pulmonary cells, in particular in normal human bronchial smooth muscle cells (HBSMCs).
IL-8 mRNA levels increased upon CSE exposure in a concentration- and time-dependent manner, and such an effect was accompanied by
IL-8 secretion. CSE-evoked elevation of
IL-8 mRNA was mimicked by its component
acrolein. Both CSE and
acrolein induced
p38 mitogen-activated protein kinase (MAPK) phosphorylation, accompanied by the phosphorylation of MAPK-activated
kinase 2 (MK2), a known downstream substrate of the
p38 MAPK, both in HBSMCs and in human airway epithelial cells. Furthermore, pharmacological inhibition of
p38 MAPK or MK2 strongly accelerated the decay of
IL-8 mRNA levels upon stimulation with CSE or
acrolein and subsequent blockade of
mRNA neosynthesis with
actinomycin D in pulmonary structural cells (HBSMCs and airways epithelial cells) as well as in human alveolar macrophages. Conversely, pharmacological inhibition of ERK1/2 signaling inhibited CSE-induced steady-state levels of
IL-8 mRNA without affecting mRNA stability, thus suggesting inhibition at the transcriptional level. In sum,
p38 MAPK/MK2 signaling is an important posttranscriptional mechanism underlying upregulation of
IL-8 mRNA levels elicited by CSE and
acrolein. Given the pivotal role of
IL-8 in neutrophil chemotaxis and activation, our results shed light on the mechanisms through which cigarette
smoke can initiate
inflammation in the lung.